CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance-Reference-Cited by-同舟云学术

CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance

Author:

Afonso Julieta¹²,Santos Lúcio L.³⁴,Miranda-Gonçalves Vera¹²,Morais António⁵,Amaro Teresina⁶,Longatto-Filho Adhemar¹²⁷⁸,Baltazar Fátima¹²

Affiliation:

1. Life and Health Sciences Research Institute (ICVS); School of Health Sciences; University of Minho; Braga Portugal

2. ICVS/3B's-PT Government Associate Laboratory; Braga/Guimarães; Portugal

3. Department of Surgical Oncology; Portuguese Institute of Oncology (IPO); Porto Portugal

4. Faculty of Health Sciences; University Fernando Pessoa (UFP); Porto Portugal

5. Department of Urology; Portuguese Institute of Oncology (IPO); Porto Portugal

6. Experimental Pathology and Therapeutics Research Center; Portuguese Institute of Oncology (IPO); Porto Portugal

7. Laboratory of Medical Investigation (LIM 14); Faculty of Medicine; São Paulo State University; São Paulo Brazil

8. Molecular Oncology Research Center; Barretos Cancer Hospital; São Paulo Brazil

Funder

Life and Health Sciences Research Institute (ICVS)

Portuguese Science and Technology Foundation (FCT)

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Reference51 articles.

4. Cancer-related issues of CD147;Weidle;Cancer Genomics Proteomics,2010

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献